Mollenhauer Brit

Prof. Mollenhauer Brit holds the Endowed Professorship for Movement Disorders at the Department of Neurology, Georg-August-Universität Göttingen, and serves as Chief Physician at the Paracelsus-Elena Clinic’s Center for Movement Disorders in Kassel. Her work focuses on neurodegenerative diseases, particularly Parkinson’s disease and synucleinopathies, with emphasis on biomarker development and disease progression mechanisms.

Her research integrates clinical, genetic, and biochemical approaches, including studies on α-synuclein pathology, CSF biomarkers, and machine learning-driven diagnostic tools. She leads multinational projects like the Parkinson’s Progression Markers Initiative (PPMI) and SPARK clinical trials, advancing early detection and therapeutic strategies.

Key contributions include developing smell tests for PD diagnosis, analyzing genetic risk factors across populations, and investigating interventional therapies like fasting protocols in rheumatoid arthritis. Her work bridges basic science and clinical practice, aiming to stratify PD subtypes for precision medicine.

Collaborations span academic institutions and industry, with active involvement in cohort studies (e.g., HeBA) to identify prodromal PD markers. Her lab focuses on biomarker validation, neuroimaging correlates, and longitudinal disease tracking using multimodal clinical milestones.